1-3 of 3
Xianghui Xiao
Close
Sort by
Journal Articles

Safety and Efficacy of Venetoclax Salvage Therapy in Relapsed/Refractory Multiple Myeloma with and without t(11;14)

Maximilian J Steinhardt, Max Bittrich, Xiang Zhou, Julia Noderer, Christine Riedhammer, Xianghui Xiao, Sophia Gawlas, Philipp Weis, Florian Eisele, Umair Munawar, Seungbin Han, Julia Mersi, Johannes M Waldschmidt, Hermann Einsele, Leo Rasche, K. Martin Kortüm
Journal: Blood
Blood (2023) 142 (Supplement 1): 6702.
https://doi.org/10.1182/blood-2023-189927
Published: 2023
Journal Articles

Prolonged Cytopenia Following CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Prospective Comprehensive Biomarker Study

Xiang Zhou, Vivien Wagner, Emilia Stanojkovska, Christine Riedhammer, Xianghui Xiao, Mara John, Lukas Scheller, Umair Munawar, Seungbin Han, Johannes M Waldschmidt, Max S. Topp, Johannes Duell, Hermann Einsele, Angela Riedel, Martin Kortüm, Leo Rasche
Journal: Blood
Blood (2023) 142 (Supplement 1): 95.
https://doi.org/10.1182/blood-2023-180534
Published: 2023
Journal Articles

Advanced Risk Stratification in Multiple Myeloma Beyond Traditional FISH: The First Prospective Real-World Evidence for SKY92 Gene Expression Profiling

Xiang Zhou, Annika Hofmann, Cornelia Vogt, Silvia Nerreter, Eva Teufel, Emilia Stanojkovska, Marietta Truger, Benedict Engel, Anastasia Barcic, Jessica Peter, Christine Riedhammer, Max Johannes Steinhardt, Xianghui Xiao, Hannah Hornburger, Seungbin Han, Larissa Haertle, Umair Munawar, Julia Mersi, Claudia Haferlach, Hermann Einsele, Leo Rasche, K. Martin Kortuem
Journal: Blood
Blood (2022) 140 (Supplement 1): 4273–4274.
https://doi.org/10.1182/blood-2022-163848
Published: 2022